Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SDGR Schrodinger Inc

0.16 (0.73%)
May 24 2024 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 445,447
Bid Price 21.90
Ask Price 22.23
News -
Day High 22.28


52 Week Range


Day Low 21.675
Company Name Stock Ticker Symbol Market Type
Schrodinger Inc SDGR NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.16 0.73% 21.98 20:00:00
Open Price Low Price High Price Close Price Prev Close
22.00 21.675 22.28 21.98 21.82
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
7,543 445,447 $ 22.04 $ 9,818,504 - 20.76 - 59.24
Last Trade Time Type Quantity Stock Price Currency
18:40:19 10 $ 22.04 USD

Schrodinger (SDGR) Options Flow Summary

Overall Flow


Net Premium


Calls / Puts


Buys / Sells




Sweeps Ratio


Schrodinger Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.59B 72.31M - 216.67M 40.72M 0.56 39.09
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Schrodinger News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SDGR Message Board. Create One! See More Posts on SDGR Message Board See More Message Board Posts

Historical SDGR Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week22.9723.3721.6622.40628,542-0.99-4.31%
1 Month23.6026.7521.6623.39831,779-1.62-6.86%
3 Months25.5329.1521.6625.17828,261-3.55-13.91%
6 Months30.6738.0021.6628.00833,531-8.69-28.33%
1 Year38.1359.2420.7634.19991,764-16.15-42.36%
3 Years64.7379.7515.8535.01779,259-42.75-66.04%
5 Years30.45117.0015.8546.59897,833-8.47-27.82%

Schrodinger Description

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. Schrodinger generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Your Recent History

Delayed Upgrade Clock